Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim
Neutrophil-to-Lymphocyte Ratio in Patients With Heart Failure: Findings From The EMPEROR Program. (PubMed, ESC Heart Fail) - Sep 19, 2026 - P3 | "In patients with CHF, a higher NLR was associated with greater congestion and poorer prognosis. The efficacy of empagliflozin was consistent, regardless of baseline NLR." 
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Inflammation
http://www.ncbi.nlm.nih.gov/pubmed/42759496
 
Faiez Zannad; Gerasimos Filippatos; Javed Butler; João Pedro Ferreira; John G F Cleland; Milton Packer; Pasquale Maffia; Pierpaolo Pellicori; Stefan D Anker
 
Sep 19, 2026
 
Prev Next